A. Scientific Foundation
Crown MycoResin Biotech Inc.’s platform is grounded in myco‑biotechnology, leveraging controlled fungal–plant interactions to stimulate defense responses, resin biosynthesis, and secondary metabolite pathways in high‑value aromatic trees.
Key biological principles include:
- Endophytic and rhizospheric fungal signaling
- Controlled biotic stress induction
- Activation of phenylpropanoid and terpenoid pathways
- Managed wound–response and resin compartmentalization
B. MycoResin™ Technology Architecture
The MycoResin™ platform consists of four integrated layers:
- Fungal Consortium Design – selection, stabilization, and compatibility screening of beneficial fungal strains
- Induction Protocols – timing, dosage, and application methods aligned to tree age and physiology
- Plant Response Monitoring – visual, anatomical, and biochemical indicators
- Field Deployment SOPs – standardized Lab‑to‑Land™ manuals for plantation use
C. Target Species (Initial Focus)
- Aquilaria malaccensis (Agarwood)
- Expansion-ready for other resinous and aromatic species (e.g., sandalwood, Cananga, champaca)
D. Deployment Methodology (Lab‑to‑Land™)
- Laboratory validation and fungal preparation
- Nursery‑stage compatibility testing
- Field inoculation and induction
- Monitoring and adaptive management
- Resin maturation and harvest optimization
E. Quality & Performance Indicators
- Resin initiation rate
- Resin density and distribution
- Aromatic compound profile (qualitative)
- Tree vitality and survival rate
- Time‑to‑harvest reduction metrics
F. IP & Data Strategy
- Proprietary formulations and application protocols
- Trade secret protection and staged IP filings
- Controlled access to SOPs and training materials
- Data ownership through deployment agreements
G. Scalability & Replicability
- Modular protocol deployment
- Training‑based technology transfer
- Compatible with cooperative, estate, and investor‑led plantation models
H. Risk & Mitigation
| Risk | Mitigation Strategy |
|---|---|
| Biological variability | Species‑specific protocols, staged rollout |
| Environmental factors | Site screening and adaptive SOPs |
| Adoption risk | Training, pilot demonstrations |
| IP leakage | Controlled licensing and documentation |
I. Regulatory & Compliance Context
- Aligned with sustainable forestry and agroforestry standards
- Supports DENR and environmental compliance frameworks
- Non‑toxic, non‑chemical induction philosophy
J. Development Roadmap
- Phase 1: Pilot validation (12–18 months)
- Phase 2: Commercial rollout (regional)
- Phase 3: International licensing and partnerships
This Technical Appendix is confidential and intended solely for qualified investors, partners, and authorized stakeholders.